Unigene Laboratories hired Alex Martin as VP, business development and head of commercial operations, a newly created position. He joins from Affectis Pharmaceuticals AG, where he most recently served as CEO. Prior to Affectis, Martin was COO, Intercept Pharmaceuticals; chief business officer and chief financial officer, BioXell; and held management positions of increasing responsibility at Novartis Pharma AG, Medscape and SmithKline Beecham.